Authors:
DEJONG RS
WILLEMSE PHB
BOONSTRA H
DEVRIES EGE
VANDERGRAAF WTA
SLEIJFER DT
VANDERZEE AGJ
MULDER NH
Citation: Rs. Dejong et al., PHASE-II STUDY OF INTRAPERITONEAL CISPLATIN PLUS SYSTEMIC ETOPOSIDE AS 2ND-LINE TREATMENT IN PATIENTS WITH SMALL-VOLUME RESIDUAL OVARIAN-CANCER, European journal of cancer, 31A(5), 1995, pp. 709-713
Authors:
VELDHUIS GJ
WILLEMSE PHB
GROENEWEGEN A
SLEIJFER DT
VANDERGRAAF WTA
MULDER NH
DEVRIES EGE
Citation: Gj. Veldhuis et al., COMBINATION OF RHIL-6 AND GM-CSF IN PATIENTS BEFORE AND AFTER CHEMOTHERAPY (CT), European journal of cancer, 31A, 1995, pp. 230-230
Authors:
VELDHUIS GJ
WILLEMSE PHB
VANDERGRAAF WTA
AALDERS JG
GROENEWEGEN A
DEVRIES EGE
Citation: Gj. Veldhuis et al., RHIL-3 AND G-CSF VS G-CSF ALONE AFTER TAXOL-IFOSFAMIDE-CISPLATIN (TIC) CHEMOTHERAPY (CT) IN RESIDUAL PROGRESSIVE OVARIAN-CANCER (OC), European journal of cancer, 31A, 1995, pp. 516-516
Authors:
WYMENGA ANM
VANDERGRAAF WTA
TIMENS W
SPIJKERVET FKL
DEVRIES EGE
MULDER NH
Citation: Anm. Wymenga et al., STUDIES ON VITALITY OF ORAL EPITHELIAL-CELLS DURING AND AFTER HIGH-DOSE CHEMOTHERAPY - A NEW ASSAY FOR QUANTITATION OF CHEMOTHERAPY-INDUCEDMUCOSITIS, European journal of cancer, 31A, 1995, pp. 1209-1209
Authors:
VANDERGRAAF WTA
ZIJLSTRA JG
DEVRIES EGE
NETHERSELL ABW
MULDER NH
Citation: Wta. Vandergraaf et al., IN-VITRO AND IN-VIVO STUDIES ON THE ACTION OF BW502U83, AN ARYLMETHYLAMINOPROPANEDIOL, Anti-cancer drugs, 6(1), 1995, pp. 34-39
Authors:
VELDHUIS GJ
WILLEMSE PHB
SLEIJFER DT
VANDERGRAAF WTA
GROEN HJM
LIMBURG PC
MULDER NH
DEVRIES EGE
Citation: Gj. Veldhuis et al., TOXICITY AND EFFICACY OF ESCALATING DOSAGES OF RECOMBINANT HUMAN INTERLEUKIN-6 AFTER CHEMOTHERAPY IN PATIENTS WITH BREAST-CANCER OR NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2585-2593
Authors:
SCHRODER CP
VANDERGRAAF WTA
KEMA IP
GROENEWEGEN A
SLEIJFER DT
DEVRIES EGE
Citation: Cp. Schroder et al., SEROTONIN METABOLISM FOLLOWING PLATINUM-BASED CHEMOTHERAPY COMBINED WITH THE SEROTONIN TYPE-3 ANTAGONIST TROPISETRON, Cancer chemotherapy and pharmacology, 36(6), 1995, pp. 477-482
Authors:
VANDERGRAAF WTA
MULDER NH
MEIJER C
DEVRIES EGE
Citation: Wta. Vandergraaf et al., THE ROLE OF METHOXYMORPHOLINO ANTHRACYCLINE AND CYANOMORPHOLINO ANTHRACYCLINE IN A SENSITIVE SMALL-CELL LUNG-CANCER CELL-LINE AND ITS MULTIDRUG-RESISTANT BUT P-GLYCOPROTEIN-NEGATIVE AND CISPLATIN-RESISTANT COUNTERPARTS, Cancer chemotherapy and pharmacology, 35(4), 1995, pp. 345-348
Authors:
DEGRAAF H
MULDER NH
WILLEMSE PHB
VANDERGRAAF WTA
SLEIJFER DT
ZIJLSTRA JG
ELIAS M
SIBINGA CTS
VELLENGA E
DEVRIES EGE
Citation: H. Degraaf et al., THE ADDITIVE EFFECT OF PERIPHERAL-BLOOD STEM-CELLS, HARVESTED WITH LOW-DOSE CYCLOPHOSPHAMIDE, TO AUTOLOGOUS BONE-MARROW REINFUSION ON HEMATOPOIETIC RECONSTITUTION AFTER ABLATIVE CHEMOTHERAPY IN BREAST-CANCER PATIENTS WITH LOCALIZED DISEASE, Anticancer research, 15(6B), 1995, pp. 2851-2856
Citation: Jthm. Plukker et al., NEOADJUVANT CHEMOTHERAPY WITH CARBOPLATIN, 4-EPIADRIAMYCIN AND TENIPOSIDE (CET) IN LOCALLY ADVANCED CANCER OF THE CARDIA AND THE LOWER ESOPHAGUS - A PHASE-II STUDY, Anticancer research, 15(5), 1995, pp. 2357-2361
Authors:
MULDER NH
DOLSMA WV
MULDER POM
DEVRIES EGE
WILLEMSE PHB
SLEIJFER DT
HOSPERS GAP
VANDERGRAAF WTA
Citation: Nh. Mulder et al., LONG-TERM RESULTS OF INDUCTION-CHEMOTHERAPY AND INTENSIFICATION CHEMOTHERAPY SUPPORTED WITH AUTOLOGOUS BONE-MARROW REINFUSION IN PATIENTS WITH DISSEMINATED OR T4 BREAST-CANCER, Anticancer research, 15(4), 1995, pp. 1565-1568
Authors:
SLEIJFER S
VANDERGRAAF WTA
WILLEMSE PHB
DEVRIES EGE
KOOPS HS
MULDER NH
Citation: S. Sleijfer et al., HIGH-DOSE METHOTREXATE, VINCRISTINE AND CISPLATIN AS SALVAGE TREATMENT FOR RELAPSED NONSEMINOMATOUS GERM-CELL CANCER, Anticancer research, 15(3), 1995, pp. 1039-1042
Authors:
BUTER J
SINNIGE HAM
SLEIJFER DT
DEVRIES EGE
WILLEMSE PHB
VANDERGRAAF WTA
VERSCHUEREN RCJ
MULDER NH
Citation: J. Buter et al., 5-FLUOROURACIL LEUCOVORIN INTERFERON ALPHA-2-ALPHA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Cancer, 75(5), 1995, pp. 1072-1076
Authors:
GIETEMA JA
VELDHUIS GJ
GUCHELAAR HJ
WILLEMSE PHB
UGES DRA
CATS A
BOONSTRA H
VANDERGRAAF WTA
SLEIJFER DT
DEVRIES EGE
MULDER NH
Citation: Ja. Gietema et al., PHASE-II AND PHARMACOKINETIC STUDY OF LOBAPLATIN IN PATIENTS WITH RELAPSED OVARIAN-CANCER, British Journal of Cancer, 71(6), 1995, pp. 1302-1307
Authors:
DEGRAAF H
WILLEMSE PHB
DEVRIES EGE
SLEIJFER DT
MULDER POM
VANDERGRAAF WTA
SIBINGA TS
VANDERPLOEG E
DOLSMA WV
MULDER NH
Citation: H. Degraaf et al., INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSFUSION AS PRIMARY-TREATMENT IN WOMEN WITH BREAST-CANCER AND MORE THAN 5 INVOLVED AXILLARY LYMPH-NODES, European journal of cancer, 30A(2), 1994, pp. 150-153
Authors:
VANDERGRAAF WTA
BUTER J
DEVRIES EGE
WILLEMSE PHB
SLEIJFER DT
MULDER NH
Citation: Wta. Vandergraaf et al., HIGH-DOSE ORAL AMIODARONE ADDED TO DOXORUBICIN AND VINDESINE FOR OVERCOMING MULTIDRUG-RESISTANCE IN SOLID TUMORS, Annals of oncology, 5(7), 1994, pp. 659-660
Authors:
DEGRAAF H
WILLEMSE PHB
SLEIJFER DT
DEVRIES EGE
VANDERGRAAF WTA
BEUKEMA J
MULDER NH
Citation: H. Degraaf et al., EFFECTIVE CONDITIONING REGIMEN FOR PREMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, Anticancer research, 14(6B), 1994, pp. 2799-2804
Authors:
BUTER J
SLEIJFER DT
WILLEMSE PHB
VANDERGRAAF WTA
DEVRIES EGE
KOOPS HS
MULDER NH
Citation: J. Buter et al., DOSE-ESCALATION OF DACARBAZINE COMBINED WITH INTERFERON ALPHA-2A, G-CSF AND ONDANSETRON IN PATIENTS WITH METASTATIC MELANOMA, Anticancer research, 14(3B), 1994, pp. 1325-1328
Authors:
ELSINGA PH
FRANSSEN EJF
VANDERGRAAF WTA
DEVRIES EGE
VISSER GM
VAALBURG W
Citation: Ph. Elsinga et al., C-11 LABELED DAUNORUBICIN - A TRACER FOR THE IN-VIVO INVESTIGATION OFMULTI DRUG-RESISTANCE, The Journal of nuclear medicine, 35(5), 1994, pp. 160000083-160000083
Authors:
VANDERGRAAF WTA
DEVRIES EGE
TIMMERBOSSCHA H
MEERSMA GJ
MESANDER G
VELLENGA E
MULDER NH
Citation: Wta. Vandergraaf et al., EFFECTS OF AMIODARONE, CYCLOSPORINE-A, AND PSC-833 ON THE CYTOTOXICITY OF MITOXANTRONE, DOXORUBICIN, AND VINCRISTINE IN NON-P-GLYCOPROTEIN HUMAN SMALL-CELL LUNG-CANCER CELL-LINES, Cancer research, 54(20), 1994, pp. 5368-5373
Authors:
KROESEN BJ
BUTER J
SLEIJFER DT
JANSSEN RAJ
VANDERGRAAF WTA
THE TH
DELEIJ L
MULDER NH
Citation: Bj. Kroesen et al., PHASE-I STUDY OF INTRAVENOUSLY APPLIED BISPECIFIC ANTIBODY IN RENAL-CELL CANCER-PATIENTS RECEIVING SUBCUTANEOUS INTERLEUKIN-2, British Journal of Cancer, 70(4), 1994, pp. 652-661
Authors:
MULDER NH
VANDERGRAAF WTA
WILLEMSE PHB
KOOPS HS
DEVRIES EGE
SLEIJFER DT
Citation: Nh. Mulder et al., DACARBAZINE (DTIC)-BASED CHEMOTHERAPY OR CHEMOIMMUNOTHERAPY OF PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA, British Journal of Cancer, 70(4), 1994, pp. 681-683
Authors:
BUTER J
SLEIJFER DT
VANDERGRAAF WTA
DEVRIES EGE
WILLEMSE PHB
MULDER NH
Citation: J. Buter et al., A PROGRESS REPORT ON THE OUTPATIENT TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA USING SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2, Seminars in oncology, 20(6), 1993, pp. 16-21